Sharon Blum
Impact in
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
- Ophthalmology top 10%
- Ocular Infections and Treatments
- Glaucoma and retinal disorders
- Intraocular Surgery and Lenses
Papers in
-
- Clostridium difficile and Clostridium perfringens research 3
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Burke A. Cunha (3 shared papers)Cheston B. Cunha (1 shared paper)Elayne Livote (1 shared paper)Kari A. Mergenhagen (1 shared paper)Kenneth S. Boockvar (1 shared paper)Jonathan R. Nebeker (1 shared paper)Michael Ott (1 shared paper)Joseph Moisseiev (1 shared paper)
- Journals
- American Journal of Infection Control (2 papers)Journal of Clinical Oncology (1 paper)BMC Ophthalmology (1 paper)The American journal of geriatric pharmacotherapy (1 paper)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesIsrael
In The Last Decade
Sharon Blum
13 papers receiving 144 citations
Peers
Comparison fields: 5 of 49
- Geriatrics and Gerontology 35
- Ophthalmology 36
- Family Practice 4
- Emergency Medical Services 13
- Applied Microbiology and Biotechnology 3
Countries citing papers authored by Sharon Blum
This map shows the geographic impact of Sharon Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Blum more than expected).
Fields of papers citing papers by Sharon Blum
This network shows the impact of papers produced by Sharon Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Blum. The network helps show where Sharon Blum may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon Blum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 47 | |
| 2 | 2015 | 23 | |
| 3 | 2017 | 18 | |
| 4 | 2019 | 17 | |
| 5 | 1992 | 14 | |
| 6 | 2018 | 10 | |
| 7 | 2021 | 8 | |
| 8 | 2022 | 5 | |
| 9 | 2019 | 5 | |
| 10 | 2014 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2018 | 1 | |
| 14 | 2023 | 0 |
About Sharon Blum
Sharon Blum is a scholar working on Infectious Diseases, Pharmacology, General Health Professions, Ophthalmology and Epidemiology, having authored 14 papers that have together received 152 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Ophthalmology and Visual Impairment Studies (1 paper), Antibiotic Use and Resistance (1 paper), Surgical site infection prevention (1 paper) and Retinal Diseases and Treatments (1 paper). The work is most often cited by research in Geriatrics and Gerontology (35 citations), Ophthalmology (36 citations), Family Practice (4 citations), Emergency Medical Services (13 citations) and Applied Microbiology and Biotechnology (3 citations). Sharon Blum has collaborated with scholars based in United States and Israel. Frequent co-authors include Burke A. Cunha, Cheston B. Cunha, Elayne Livote, Kari A. Mergenhagen, Kenneth S. Boockvar, Jonathan R. Nebeker, Michael Ott, Joseph Moisseiev, Megan McLaughlin and Ruth Axer‐Siegel. Their work appears in journals such as American Journal of Infection Control, Journal of Clinical Oncology, BMC Ophthalmology, The American journal of geriatric pharmacotherapy and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.